Psilocybin for Depression
Journal watch November 6, 2020
Exploratory studies have examined the usefulness of the hallucinogen psilocybin for depressed cancer patients and patients with treatment-resistant
Journal watch
ISSN 0896-7210
5 papers in the library · publishing 1996-2020
Papers
Can Psilocybin Treat Severe Depression
Journal watch November 3, 2017
In 1970, the FDA categorized psilocybin as a Schedule 1 drug, largely because of its recreational uses, which include inducing spirituality and
It’s Not Benign: Cannabis, Cognition, and Psychosis
Journal watch December 28, 2007 Deborah Cowley
Despite persistent questions about causality and the confounding of results, this past year has seen the strongest evidence to date of an association
Controlling Nightmares with Imagery Rehearsal Therapy
Journal watch 2001 Gilbert M. Tucker
Recurrent nightmares are common in patients with post-traumatic stress disorder (PTSD), but rarely are nightmares treated directly. These researchers randomized 168 women with chronic nightmares and DSM-IIIR-diagnosed PTSD to receive imagery rehearsal therapy (IRT) or to be placed on a wait list (control group). Of the participants, 79 percent were …
Risperidone May Be Contraindicated in Post-LSD Visual Disorder
Journal watch September 1, 1996 Peter Roy‐Byrne
Numerous reports have documented persistent visual disturbances (i.e., afterimages, light flashes, geometric pseudohallucinations, and image trails) in